Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Alzheon Appoints Chair

This article was originally published in Scrip

Executive Summary

Alzheon, Inc. has appointed former GlaxoSmithKline CEO Jean-Pierre Garnier chair of its board of directors. From 2000 to 2008, Garnier was the first CEO of GSK after SmithKline Beecham and Glaxo Wellcome merged and before that he was CEO of SmithKline Beecham. Prior to this he was president of Schering-Plough and after his retirement from GSK, he was CEO of Pierre Fabre Laboratories and chair of Cerenis (US).

Advertisement
Advertisement
UsernamePublicRestriction

Register